-Reuters
Save time and jump to the most important pieces.
NANPING, China, March 13, 2023 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) is pleased to announce that effective on March 14, 2023, the Company will change its name to "Paranovus Entertainment Technology Ltd.", which better reflects the Company's strategic business expansion and less limiting than the current name. In connection with the name change, the trading symbol of the Class A ordinary shares will be changed to "PAVS" on the Nasdaq Stock Market, effective on March 14, 2023. Xuezhu Wang, the CEO and the Chairman of the Board of the Company, commented, "This new name will reflect the company's evolving focus and strategy. The company is p
NANPING, China, Oct. 27, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) announced today that on October 25, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On November 11, 2021, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until May 10, 2
NANPING, China, Oct. 10, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that an 1 for 20 reverse split of its ordinary shares, par value $0.0005 each, was approved by the Company's shareholders on October 7, 2022 and became effective on October 10, 2022. In connection with the reverse share split, the Company's shareholders will receive one new ordinary share of the Company for every twenty shares they hold. The Company's o
6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)
6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)
6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)
SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)
SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)
SC 13D/A - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)
NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced its unaudited financial results for the six months ended September 30, 2021. Financial Highlights for the six months ended September 30, 2021: Revenues increased by $25.01 million or 114.3%, to $46.88 million for the six months ended September 30, 2021 from $21.88 million for the six months ended September 30, 2020, mainly due to the start-up of new goods or service
NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited ((the ", Company", NASDAQ:HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration. Fujian Shennong is a company with a solid customer's base, focusing on the trading of a
NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2020 and provided the guidance for the whole fiscal year ending March 31, 2021. Financial Highlights for the six months ended September 30, 2020: Revenues decreased by $9.48 million or 30.2%, to $21.88 million for the six months ended September 30, 2020 from $31.36 million for the six months ended September 30, 2019, mainly due to the declining retail market affected by the COVID-19. Operating income was $3.69 million fo
Gainers CinCor Pharma, Inc. (NASDAQ:CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion. Amryt Pharma plc (NASDAQ:AMYT) shares rose 112% to $14.86 in pre-market trading after Chiesi Farmaceutici S.p.A. announced plans to acquire the company. Apexigen, Inc. (NASDAQ:APGN) rose 92.4% to $1.81 in pre-market trading after climbing more than 10% on Friday. Albireo Pharma, Inc. (NASDAQ:ALBO) shares rose 87.3% to $42.73 in pre-market trading. Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 53.4% to $2.01 in pre-market trading. Bed Bath & Beyond shares dropped over 22% on Friday following a report indicating the company could
-Reuters
Gainers Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares jumped 140% to $0.6041 after the company entered into a definitive merger agreement with GRI Bio. Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 52% to $0.2175. Panbela received EMA opinion on orphan designation for Ivospemin in combination with Gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma. Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 46% to $2.1695 after the company announced it has in-licensed BCMA-targeted next-